Perspective Therapeutics (CATX) Selling, General & Administrative (2010 - 2026)
Perspective Therapeutics (CATX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | 7.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.80 Mn |
| Mar 31, 2026 | 6.99 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 8.25 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 4.94 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 6.66 Mn |
| Dec 31, 2022 | 4.85 Mn |
| Sep 30, 2022 | 6.28 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 1.58 Mn |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 1.13 Mn |
| Sep 30, 2020 | 1.07 Mn |